drugset / Trial / NCT01990885

Safety and Systemic Exposure Study of BL-7010 in Well-Controlled Celiac Patients.

NCT01990885 ↗

Phase 1/2 Completed 40 enrolled BioLineRx, Ltd.
RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this study is to evaluate the safety of different amounts of BL-7010 in single oral administration and in repeated oral administration to well-controlled celiac patients. Another purpose is to evaluate if BL-7010 is absorbed by the body or not.

Timeline

Start
2013-12
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject BL-7010 Unknown — Oral

Indications